Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Actuate Therapeutics Inc.
Pfizer
Avera McKennan Hospital & University Health Center
M.D. Anderson Cancer Center
Carevive Systems, Inc.
University of Florida
Essen Biotech
University of Nebraska
Adela, Inc
M.D. Anderson Cancer Center
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Salamanca
Cancer Research UK
University Health Network, Toronto
Mayo Clinic
Massive Bio, Inc.
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Dana-Farber Cancer Institute
Washington University School of Medicine
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Inova Health Care Services
Cedars-Sinai Medical Center
Assistance Publique Hopitaux De Marseille
National Cancer Institute (NCI)
University Health Network, Toronto
Taproot Health
Cedars-Sinai Medical Center
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
Eastern Cooperative Oncology Group
Maastricht University Medical Center
Global BioClinical
Hospital General Universitario de Valencia
Blue Note Therapeutics
Weprom
National Institutes of Health Clinical Center (CC)
Seoul National University Hospital
Pfizer
Hospital General Universitario de Valencia
Celgene
University of Wisconsin, Madison
LEO Pharma
Shenzhen BinDeBio Ltd.
CureOne
Butler Hospital